Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma
- PMID: 25964311
- PMCID: PMC4490880
- DOI: 10.1093/neuonc/nov071
Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma
Comment on
-
Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma.Neuro Oncol. 2015 Aug;17(8):1064-75. doi: 10.1093/neuonc/nou307. Epub 2014 Oct 29. Neuro Oncol. 2015. PMID: 25355681 Free PMC article.
References
-
- Chen DS, Mellman I. Oncology meets immunology: the cancer-immunity cycle. Immunity. 2013;39(1):1–10. - PubMed
-
- Yervoy [package insert]. Princeton, NJ, Bristol-Myers Squibb, 2013.
-
- Keytruda [package insert]. Whitehouse Station, NJ: Merck & Co., 2015.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
